Skip to main content

Molecular Mechanisms Underlying C9orf72 Neurodegeneration, Volume II

Cover image for Research Topic "Molecular Mechanisms Underlying C9orf72 Neurodegeneration, Volume II"
62kviews
Editorial08 January 2024
Editorial: Molecular mechanisms underlying C9orf72 neurodegeneration, volume II
Jean-Marc Gallo, Agnes Nishimuraand Annakaisa Haapasalo

The most common genetic cause of familial and sporadic amyotrophic lateral sclerosis (ALS) 19 and frontotemporal dementia (FTD) is a GGGGCC hexanucleotide repeat expansion in the 20 C9orf72 gene (Balendra Isaacs, 2018), defining a group of neurodegenerative diseases 21 collectively referred to as c9ALS/FTD. Three pathological mechanisms have been implicated in c9ALS/FTD: sense and antisense repeat RNA form RNA foci that sequester specific RNA-23 binding proteins, impairing their normal function (Barker et al., 2017;(Swinnen et al., 2020); 24 sense and antisense RNA repeats are translated into the three possible reading frames by 25 repeat-associated non-AUG-initiated (RAN) translation resulting in the production of five 26 dipeptide repeat proteins (DPRs), namely poly-GA, poly-GP, poly-GR, poly-PA and poly-PR.

Arginine-rich DPRs (poly-GR and poly-PR) cause severe neurodegeneration in Drosophila 28 (Mizielinska et al., 2014) and disrupt the formation of membraneless organelles, including 29 stress granules (Solomon et al., 2021). Finally, haploinsufficiency resulting in reduced levels

In particular, they highlight the effect of both repeat RNA-and DPR-mediated toxicity on the 77 nuclear pore complex and on components of the nucleocytoplasmic transport machinery,

1,801 views

1 citations

Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two adult-onset neurodegenerative diseases that are part of a common disease spectrum due to clinical, genetic, and pathological overlap. A prominent genetic factor contributing to both diseases is a hexanucleotide repeat expansion in a non-coding region of the C9orf72 gene. This mutation in C9orf72 leads to nuclear depletion and cytoplasmic aggregation of Tar DNA-RNA binding protein 43 (TDP-43). TDP-43 pathology is characteristic of the majority of ALS cases, irrespective of disease causation, and is present in approximately 50% of FTD cases. Defects in nucleocytoplasmic transport involving the nuclear pore complex, the Ran-GTPase cycle and nuclear transport factors have been linked with mislocalization of TDP-43. Here we will explore and discuss the implications of these system abnormalities of nucleocytoplasmic transport in C9orf72-ALS/FTD, as well as in other forms of familial and sporadic ALS.

8,949 views

23 citations

Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology
The proper functioning of the cell clearance machinery is critical for neuronal health within the central nervous system. In normal physiological conditions, the cell clearance machinery is actively involved in the elimination of misfolded and toxic proteins throughout the lifetime of an organism. The highly conserved and regulated pathway of autophagy is one of the important processes involved in preventing and neutralizing pathogenic build up of toxic proteins that could eventually lead to the development of neurodegenerative diseases such as Alzheimer’s disease or Amyotrophic lateral sclerosis (ALS). The most common genetic cause of ALS and frontotemporal dementia (FTD) is a hexanucleotide expansion consisting of GGGGCC (G4C2) repeats in the chromosome 9 open reading frame 72 gene (C9ORF72). These abnormally expanded repeats have been implicated in leading to three main modes of disease pathology: loss of function of the C9ORF72 protein, the generation of RNA foci, and the production of dipeptide repeat proteins (DPRs). In this review, we discuss the normal physiological role of C9ORF72 in the autophagy-lysosome pathway (ALP), and present recent research deciphering how dysfunction of the ALP synergizes with C9ORF72 haploinsufficiency, which together with the gain of toxic mechanisms involving hexanucleotide repeat expansions and DPRs, drive the disease process. This review delves further into the interactions of C9ORF72 with RAB proteins involved in endosomal/lysosomal trafficking, and their role in regulating various steps in autophagy and lysosomal pathways. Lastly, the review aims to provides a framework for further investigations of neuronal autophagy in C9ORF72-linked ALS-FTD as well as other neurodegenerative diseases.

11,503 views

36 citations

ORIGINAL RESEARCH
17 April 2023
C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
Maria-Belen Lopez-Herdoiza, 23 more and Morwena Latouche

6,889 views

13 citations

Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
ORIGINAL RESEARCH
16 December 2022
Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation
Claudia S. Bauer, 13 more and Kurt J. De Vos
Disruption to protein homeostasis caused by lysosomal dysfunction and associated impairment of autophagy is a prominent pathology in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). The most common genetic cause of ALS/FTD is a G4C2 hexanucleotide repeat expansion in C9orf72 (C9ALS/FTD). Repeat-associated non-AUG (RAN) translation of G4C2 repeat transcripts gives rise to dipeptide repeat (DPR) proteins that have been shown to be toxic and may contribute to disease aetiology. Genetic variants in TMEM106B have been associated with frontotemporal lobar degeneration with TDP-43 pathology and disease progression in C9ALS/FTD. TMEM106B encodes a lysosomal transmembrane protein of unknown function that is involved in various aspects of lysosomal biology. How TMEM106B variants affect C9ALS/FTD is not well understood but has been linked to changes in TMEM106B protein levels. Here, we investigated TMEM106B function in the context of C9ALS/FTD DPR pathology. We report that knockdown of TMEM106B expression exacerbates the accumulation of C9ALS/FTD-associated cytotoxic DPR proteins in cell models expressing RAN translated or AUG-driven expression of DPRs as well as in C9ALS/FTD-derived iAstrocytes with an endogenous G4C2 expansion by impairing autophagy. Loss of TMEM106B caused a block late in autophagy by disrupting autophagosome to autolysosome maturation which coincided with impaired lysosomal acidification, reduced cathepsin activity, and juxtanuclear clustering of lysosomes. Lysosomal clustering required Rab7a and coincided with reduced Arl8b-mediated anterograde transport of lysosomes to the cell periphery. Increasing Arl8b activity in TMEM106B deficient cells not only restored the distribution of lysosomes, but also fully rescued autophagy and DPR protein accumulation. Thus, we identified a novel function of TMEM106B in autophagosome maturation via Arl8b. Our findings indicate that TMEM106B variants may modify C9ALS/FTD by regulating autophagic clearance of DPR proteins. Caution should therefore be taken when considering modifying TMEM106B expression levels as a therapeutic approach in ALS/FTD.

7,627 views

16 citations

ORIGINAL RESEARCH
15 December 2022
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data
Ahmad Al Khleifat, 43 more and Ammar Al-Chalabi

5,907 views

12 citations